Detalhe da pesquisa
1.
Hidden in plain sight - Survival consequences of baseline symptom burden in women with recurrent ovarian cancer.
Gynecol Oncol
; 185: 128-137, 2024 Feb 26.
Artigo
Inglês
| MEDLINE | ID: mdl-38412736
2.
Danish value sets for the EORTC QLU-C10D utility instrument.
Qual Life Res
; 33(3): 831-841, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38183563
3.
Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial.
Lancet Oncol
; 24(5): 468-482, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37080223
4.
Patient-Reported Outcome Measures in Chemotherapy-Induced Peripheral Neurotoxicity: Defining Minimal and Clinically Important Changes.
J Natl Compr Canc Netw
; 21(2): 125-132.e3, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36791763
5.
Evaluating patient-reported symptoms and late adverse effects following completion of first-line chemotherapy for ovarian cancer using the MOST (Measure of Ovarian Symptoms and Treatment concerns).
Gynecol Oncol
; 164(2): 437-445, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34955238
6.
Measure of Ovarian Symptoms and Treatment concerns (MOST) indexes and their associations with health-related quality of life in recurrent ovarian cancer.
Gynecol Oncol
; 166(2): 254-262, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35718565
7.
The FACT-8D, a new cancer-specific utility algorithm based on the Functional Assessment of Cancer Therapies-General (FACT-G): a Canadian valuation study.
Health Qual Life Outcomes
; 20(1): 97, 2022 Jun 16.
Artigo
Inglês
| MEDLINE | ID: mdl-35710417
8.
Symptom burden and quality of life with chemotherapy for recurrent ovarian cancer: the Gynecologic Cancer InterGroup-Symptom Benefit Study.
Int J Gynecol Cancer
; 32(6): 761-768, 2022 06 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35086926
9.
Perceived benefits and limitations of using patient-reported outcome measures in clinical practice with individual patients: a systematic review of qualitative studies.
Qual Life Res
; 31(6): 1597-1620, 2022 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-34580822
10.
Knowledge translation concerns for the CONSORT-PRO extension reporting guidance: a review of reviews.
Qual Life Res
; 31(10): 2939-2957, 2022 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-35347521
11.
Assessing chemotherapy-induced peripheral neuropathy with patient reported outcome measures: a systematic review of measurement properties and considerations for future use.
Qual Life Res
; 31(11): 3091-3107, 2022 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-35596913
12.
Improving the patient-reported outcome sections of clinical trial protocols: a mixed methods evaluation of educational workshops.
Qual Life Res
; 31(10): 2901-2916, 2022 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-35553325
13.
The use of proxies and proxy-reported measures: a report of the international society for quality of life research (ISOQOL) proxy task force.
Qual Life Res
; 31(2): 317-327, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-34254262
14.
Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trials.
BMC Cancer
; 21(1): 1083, 2021 Oct 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34620124
15.
Development and validation of the measure of ovarian symptoms and treatment concerns for surveillance (MOST-S26): An instrument to complement the clinical follow-up of women with ovarian cancer after completion of first-line treatment.
Gynecol Oncol
; 163(2): 398-407, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34481610
16.
A Comparison of Generic and Condition-Specific Preference-Based Measures Using Data From Nivolumab Trials: EQ-5D-3L, Mapping to the EQ-5D-5L, and European Organisation for Research and Treatment of Cancer Quality of Life Utility Measure-Core 10 Dimensions.
Value Health
; 24(11): 1651-1659, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34711366
17.
The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set.
Value Health
; 24(6): 862-873, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-34119085
18.
How is quality of life defined and assessed in published research?
Qual Life Res
; 30(8): 2109-2121, 2021 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-33792834
19.
Patient-reported outcomes in non-muscle invasive bladder cancer: a mixed-methods systematic review.
Qual Life Res
; 30(2): 345-366, 2021 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-32960394
20.
Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.
Lancet Oncol
; 21(5): 685-698, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32203696